Dr. Cameron Clokie is an oral and maxillofacial surgeon. He is also an entrepreneur in the medical industry. He is the current Chief Executive Officer of Induce Biologics Incorporation. Induce Biologics Inc. is a medical company specializing in regenerative medicine focused on availing the necessary innovations and resolutions in the musculoskeletal reconstruction field.
According to Crunchbase, Dr. Cameron Clokie was also the professor of Oral and Maxillofacial Surgery at the University of Toronto before resigning in 2017. He was named the head of Oral and Maxillofacial Surgery in the same institution in 1998.
Dr. Cameron has been involved in academic dentistry and clinical practice for 30 years. He has held numerous positions as a board member and an advisor to several companies.
Dr. Cameron Clokie underwent a thorough education and training before being licensed as a surgeon. He acquired his Doctor of Dental surgery in 1985 from the McGill University. He also obtained his Diploma in Oral and Maxillofacial Surgery and a doctorate in bone regeneration associated with interface developments of dental implants from the same institution. Dr. Cameron has a doctorate in philosophy too.
The Oral and Maxillofacial Surgeon has contributed a lot in the field of science and medicine through his written works.
He has written writings that have been promulgated on national and international platforms. A good number of his writings have been on regenerative medicine and bone reconstruction that is his primary practice. He has also held talks and lectures on the same.
Dr. Cameron pioneered the technique of carrying out surgery on tumors in the jaw. The technique involves using proteins to transform the stem cells of adults into bone tissue. Read more: Toronto Dentist Cameron Clokie Talks Up New Technology Available to Oral Surgeons
The technique in 2003 enabled a man who had lost approximately seven centimeters of his jaw bone following surgery to remove a tumor from the jaw, regrow his lost jaw bone again. The patient is among the eight patients that have undergone the treatment.
He holds 25 patents, some of the patents are from the United States while others are international.
Some of the patents are related to bone healing. The patents have enabled him to develop alliances with companies that have turned his knowledge and skills into commercial enterprises.